Acadian Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$108K Buy
+8,093
New +$101K ﹤0.01% 1724
2026
Q2
– Sell
-2,679
Closed -$33K – 2172
2026
Q1
$33K Buy
+2,679
New +$30.4K ﹤0.01% 1900
2024
Q4
– Sell
-2,309
Closed -$23K – 2022
2024
Q3
$23K Buy
+2,309
New +$22.8K ﹤0.01% 1960
2023
Q4
– Sell
-22,691
Closed -$137K – 1780
2023
Q3
$137K Sell
22,691
-147,797
-87% -$1.21M ﹤0.01% 1258
2023
Q2
$1.32M Buy
170,488
+39,833
+30% +$226K 0.01% 814
2023
Q1
$744K Buy
130,655
+2,804
+2% +$14.7K ﹤0.01% 954
2022
Q4
$752K Hold
127,851
– – ﹤0.01% 920
2022
Q3
$408K Buy
127,851
+13,635
+12% +$54.6K ﹤0.01% 1044
2022
Q2
$511K Buy
114,216
+108,709
+1,974% +$434K ﹤0.01% 964
2022
Q1
$29K Buy
+5,507
New +$49.6K ﹤0.01% 1525

Other funds holding ORIC

Acadian Asset Management's ORIC Position: Q3 2026 in Review

Acadian Asset Management opened a new position in Oric Pharmaceuticals (ORIC) in Q3 2026: 8,093 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1724 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in ORIC as recently as Q1 2026.

Acadian Asset Management first reported a position in ORIC in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.32M in Q2 2023. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Acadian Asset Management held 8,093 shares of Oric Pharmaceuticals worth $108K as of Q3 2026.
  • Oric Pharmaceuticals was a new Acadian Asset Management position in Q3 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q3 2026, its #1724 holding.
  • Acadian Asset Management first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
  • Acadian Asset Management's Oric Pharmaceuticals position peaked at $1.32M in Q2 2023.
  • 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Acadian Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.